RTTNews | Jan 7, 2022 07:15AM EST

07:14 Friday, January 7, 2022 (RTTNews.com) - 908 Devices (MASS) announced that GlaxoSmithKline (GSK) has purchased an additional REBEL cell culture media analyzer. GSK will now have a total of five REBEL analyzers being used by its biologics and vaccine process development teams.

REBEL is the first miniature CE-MS-based analyzer that enables biopharma researchers to accelerate process development cycles and maximize bioreactor utilization by running media analysis at-line. 908 Devices noted that there are now 15 customers owning multiple REBEL devices, more than double from a year ago.

Read the original article on RTTNews ( https://www.rttnews.com/3253532/908-devices-gsk-selects-rebel-desktop-device-as-part-of-its-process-development-efforts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2022 RTTNews.com All Rights Reserved